Back to Journals » Breast Cancer: Targets and Therapy » Volume 16
Breast Cancer: Targets and Therapy
- View all (710)
- Volume 18, 2026 (59)
- Volume 17, 2025 (104)
- Volume 16, 2024 (76)
- Volume 15, 2023 (79)
- Volume 14, 2022 (41)
- Volume 13, 2021 (58)
- Volume 12, 2020 (27)
- Volume 11, 2019 (32)
- Volume 10, 2018 (24)
- Volume 9, 2017 (64)
- Volume 8, 2016 (26)
- Volume 7, 2015 (36)
- Volume 6, 2014 (20)
- Volume 5, 2013 (13)
- Volume 4, 2012 (22)
- Volume 3, 2011 (16)
- Volume 2, 2010 (9)
- Volume 1, 2009 (4)
Archive: Volume 16, 2024
- default (76)
- Targeting Triple-Negative Breast Cancers: Modern Advancements and Future Directions (4)
Correlation of Histopathological and Radiological Response Patterns and Their Prognostic Implications in Breast Cancer After Neoadjuvant Chemotherapy
Bozer A, Yilmaz C, Çetin Tunçez H, Kocatepe Çavdar D, Adıbelli ZH
Breast Cancer: Targets and Therapy 2024, 16:1005-1017
Published Date: 31 December 2024
Quercetin Promote the Chemosensitivity in Organoids Derived from Patients with Breast Cancer
Meng S, Cao Y, Lu L, Li X, Sun S, Jiang F, Lu J, Fan D, Han X, Yao T
Breast Cancer: Targets and Therapy 2024, 16:993-1004
Published Date: 20 December 2024
Preoperative Prediction of Breast Cancer Histological Grade Using Intratumoral and Peritumoral Radiomics Features from T2WI and DWI MR Sequences
Guo Y, Liao J, Li S, Shang Y, Wang Y, Wu Q, Wu Y, Wang M, Yan F, Tan H
Breast Cancer: Targets and Therapy 2024, 16:981-991
Published Date: 19 December 2024
The History of Breast Cancer Early Detection: 1865 – 2020
Gump FE, Parmar P, Feldman S, Gupta AM
Breast Cancer: Targets and Therapy 2024, 16:973-980
Published Date: 17 December 2024
The Clinical Study of Intratumoral and Peritumoral Radiomics Based on DCE-MRI for HER-2 Positive and Low Expression Prediction in Breast Cancer
Shang Y, Wang Y, Guo Y, Li S, Liao J, Hai M, Wang M, Tan H
Breast Cancer: Targets and Therapy 2024, 16:957-972
Published Date: 14 December 2024
A Prospective Tumour Marker for Breast Cancer: YWHAB and Its Role in Promoting Oncogenic Phenotypes
Gopaul VL, Winstone L, Gatien BG, Nault BD, Maiti S, Opperman RM, Majumder M
Breast Cancer: Targets and Therapy 2024, 16:935-956
Published Date: 14 December 2024
Exploring the Complexity of Pan-Cancer: Gene Convergences and in silico Analyses
Teodoro L, Carreira ACO, Sogayar MC
Breast Cancer: Targets and Therapy 2024, 16:913-934
Published Date: 13 December 2024
A Novel Peroxisome-Related Gene Signature Predicts Breast Cancer Prognosis and Correlates with T Cell Suppression
Wang Y, Xu S, Liu J, Qi P
Breast Cancer: Targets and Therapy 2024, 16:887-911
Published Date: 9 December 2024
Comparison of Hematological Parameters and the Associated Factors Among Women with and without Breast Cancer: A Case-Control Study
Abbas AB, Al-Gamei S, Naser A, Al-Oqab A, Alduhami K, Al-Sabri M, AL-Qasem A, Gharama M, Mohammed A, Ahmed S, Al-Glal M
Breast Cancer: Targets and Therapy 2024, 16:877-885
Published Date: 10 December 2024
Psychological Stress and Its Correlations to Patients with Acute Lymphedema After Breast Cancer Surgery
Ge LP, Tang L, Zuo W, Zhou C, Gao T, Li Y, Fu C, Qiu J, Li P, Lu R, Chen L, Xue Y, Shen Z, Shao Z, Di G, Feng W
Breast Cancer: Targets and Therapy 2024, 16:867-876
Published Date: 6 December 2024
Role of Harmaline in Inhibiting c-Myc, Altering Molecular Typing, and Promoting Apoptosis in Triple-Negative Breast Cancer
Xu H, Ma Y, Li H, Song X, Liu Y, Mierzhakenmu Z, Yan K, Xu R, Zhao Z, Yuan H, Dong C
Breast Cancer: Targets and Therapy 2024, 16:855-866
Published Date: 5 December 2024
Feasibility Study of Pyrrolitinib-Based Dual-Target Therapy for Neoadjuvant Treatment of HER2-Positive Breast Cancer Patients
Zhao F, Zhang H
Breast Cancer: Targets and Therapy 2024, 16:845-853
Published Date: 29 November 2024
Dysregulation of Fatty Acid Metabolism in Breast Cancer and Its Targeted Therapy
Chang Y, Du R, Xia F, Xu X, Wang H, Chen X
Breast Cancer: Targets and Therapy 2024, 16:825-844
Published Date: 29 November 2024
Efficacy and Survival Analysis of Radiotherapy for Internal Mammary Lymph Nodes After Modified Radical Mastectomy for T1-3N3M0 the Lateral Quadrant Breast Cancer
Han X, Jiang D, Zhu C, Li D, Yin H
Breast Cancer: Targets and Therapy 2024, 16:811-823
Published Date: 26 November 2024
Identification and Validation of circDOCK1/miR-138-5p/GRB7 Axis for Promoting Breast Cancer Progression
Zhang Y, Yang M, Wang Y, Zhao J, Lee PY, Ma Y, Qu S
Breast Cancer: Targets and Therapy 2024, 16:795-810
Published Date: 26 November 2024
Unfavorable Prognostic Impact of HER2 2+/FISH-Negativity in Older Patients with HER2-Negative and High-Risk Breast Cancer
Wang H, Yu M, Chen M, Li H, Liu S
Breast Cancer: Targets and Therapy 2024, 16:785-793
Published Date: 19 November 2024
Neuron-Specific Gene Family Member 1 is a Potential New Therapeutic Target Associated with Immune Cell Infiltration for Breast Cancer
Zhang H, Li Y, Wang R, Hu X, Wang Z
Breast Cancer: Targets and Therapy 2024, 16:769-783
Published Date: 15 November 2024
Aneuploid Circulating Endothelial Cells with Prognostic Value in Locally Advanced Breast Cancer Patients After Neoadjuvant Chemotherapy
Li M, Liu Y, Han X, Li T, Zhang Z, Xue N, Liang M, Ma G, Xia T
Breast Cancer: Targets and Therapy 2024, 16:761-768
Published Date: 12 November 2024
Analysis of the Effects of Different Chemotherapy Methods on Blood Lipid Levels in Breast Cancer Patients
Mu J, Zhou M, Jiao G
Breast Cancer: Targets and Therapy 2024, 16:745-760
Published Date: 11 November 2024
Serum Direct Bilirubin as a Biomarker for Breast Cancer
Hu J, Cai Y, Chen Y, Zhu X
Breast Cancer: Targets and Therapy 2024, 16:735-743
Published Date: 7 November 2024
Targeting erbB Pathways in Breast Cancer: Dual Kinase Inhibition for Brain Metastasis and Prevention of p185HER2/Neu Tumor Development
Goel PN, Katsumata M, Qian W, Mathur S, Ji MQ, Samanta A, Grover P, Sgouros G, Chang JC, Greene MI
Breast Cancer: Targets and Therapy 2024, 16:725-733
Published Date: 30 October 2024
Transcription Factor Forkhead Box Protein 3 (FOXP3) as a Prognostic Indicator for Postoperative Outcomes in Patients with Breast Cancer: Establishment of a Prognostic Nomogram
Tan C, Xu J, Zhang S, Liu S, Yang X, Wu D, Yu B, Huang Y
Breast Cancer: Targets and Therapy 2024, 16:705-723
Published Date: 21 October 2024
Intermediate Filaments in Breast Cancer Progression, and Potential Biomarker for Cancer Therapy: A Narrative Review
Shalannandia WA, Chou Y, Bashari MH, Khairani AF
Breast Cancer: Targets and Therapy 2024, 16:689-704
Published Date: 14 October 2024
The Potential Role of SNRPD1 Stabilized by IGF2BP2 in the Progression of Triple-Negative Breast Cancer
Liu S, Sun X, Liu N, Lin F
Breast Cancer: Targets and Therapy 2024, 16:679-688
Published Date: 11 October 2024
Improved Prognosis in HER2-Low Breast Cancer Patients with Reduced Ki67 Index After Neoadjuvant Chemotherapy: A Multi-Center Retrospective Study
Huang M, Jin Y, Wang M, Song Q, Fan Y, Zhang Y, Tian C, Zhang C, Liu S
Breast Cancer: Targets and Therapy 2024, 16:667-678
Published Date: 10 October 2024
Human Leukocyte Antigen Class I Expression and Natural Killer Cell Infiltration and Its Correlation with Prognostic Features in Luminal Breast Cancers
Vernet-Tomas M, Vazquez I, Olivares F, Lopez D, Yelamos J, Comerma L
Breast Cancer: Targets and Therapy 2024, 16:657-666
Published Date: 5 October 2024
Investigating the Correlation Between Long-Term Response in Patients with Metastatic HER2+ Breast Cancer and the Activity of Regulatory T Cells: A Retrospective Study
Degirmenci M, Diniz G, Kahraman DS, Sahbazlar M, Koral L, Varol U, Uslu R
Breast Cancer: Targets and Therapy 2024, 16:645-655
Published Date: 27 September 2024
Plasma Exosome miR-203a-3p is a Potential Liquid Biopsy Marker for Assessing Tumor Progression in Breast Cancer Patients
Yang X, Fan L, Huang J, Li Y
Breast Cancer: Targets and Therapy 2024, 16:631-643
Published Date: 18 September 2024
Comparative Analysis and Future Prospects of Human Epidermal Growth Factor Receptor 2 (HER2) and Trophoblast Cell-Surface Antigen 2 (Trop-2) Targeted Antibody-Drug Conjugates in Breast Cancer Treatment
Gao X, Bu T, Wang W, Xu Y
Breast Cancer: Targets and Therapy 2024, 16:621-630
Published Date: 17 September 2024
Ultra-Hypofractionated Whole Breast Radiotherapy with Automated Hybrid-VMAT Technique: A Pilot Study on Safety, Skin Toxicity and Aesthetic Outcomes
Boccardi M, Cilla S, Fanelli M, Romano C, Bonome P, Ferro M, Pezzulla D, Di Marco R, Deodato F, Macchia G
Breast Cancer: Targets and Therapy 2024, 16:611-619
Published Date: 16 September 2024
Elevated Risk of Adverse Prognosis in Patients with T2-3 Stage Breast Cancer Exhibiting Non-Pathological Complete Response Following Neoadjuvant Chemotherapy: Significance of Regenerating Islet-Derived Family Member 4
Li F, Chen CG, Wei JF, Lin JW, Dou ZA, Shen J, Li SQ
Breast Cancer: Targets and Therapy 2024, 16:595-610
Published Date: 12 September 2024
Unraveling the Role of PCDH9 in Breast Cancer and Identifying Therapeutic Strategies for PCDH9-Deficient Tumors
Li R, Liu L, Liu Y, Tang J, Li J
Breast Cancer: Targets and Therapy 2024, 16:583-593
Published Date: 9 September 2024
Comparative Analysis of Dosimetry: IMRT versus 3DCRT in Left-Sided Breast Cancer Patients with Considering Some Organs in Out - of – Field Borders
Ghazy SG, Abdel-Maksoud MA, Saleh IA, El-Tayeb MA, Elsaid AA, Kotb MA, Al-Sherif DA, Ramadan HS, Elwahsh A, Hussein AM, Kodous AS
Breast Cancer: Targets and Therapy 2024, 16:567-582
Published Date: 5 September 2024
Antimicrobial and Cytotoxic Effect of Bornetella Nitida Green Algae Isolate on MCF-7 Breast Cancer
Hadisaputri YE, Soekamto NH, Pudjiastuti P, Aristokrat A, Bahrun B, Abdullah FF, Okino T
Breast Cancer: Targets and Therapy 2024, 16:555-565
Published Date: 4 September 2024
Ranking of Modifiable Lifestyle Risk Factors for Breast Cancer in Saudi Women: Population Attributable Risk and Nomogram
Alsayer RM, De Vol EB, Almeharish A, Alfattani A, Alghamdi AJ, AlBehlal LB, Alhaddab S, Altwaijri Y
Breast Cancer: Targets and Therapy 2024, 16:545-554
Published Date: 2 September 2024
A Prognostic Risk Signature of Two Autophagy-Related Genes for Predicting Triple-Negative Breast Cancer Outcomes
Yu B, Xing Z, Tian X, Feng R
Breast Cancer: Targets and Therapy 2024, 16:529-544
Published Date: 2 September 2024
Practical Guidance on Abemaciclib in Combination with Adjuvant Endocrine Therapy for Treating Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative High-Risk Early Breast Cancer
O'Keefe K, Desai NV, Tan AR
Breast Cancer: Targets and Therapy 2024, 16:517-527
Published Date: 29 August 2024
Recent Advances in Immunotherapy for Breast Cancer: A Review
Wen QE, Li L, Feng RQ, Li DH, Qiao C, Xu XS, Zhang YJ
Breast Cancer: Targets and Therapy 2024, 16:497-516
Published Date: 27 August 2024
Comprehensive Assessment of Immune Phenotype and Its Effects on Survival Outcomes in HER2-Low versus HER2-Zero Breast Cancer
Ko HC, Seager RJ, Pabla S, Senosain MF, Van Roey E, Gao S, Strickland KC, Previs RA, Green MF, Cooper M, Nesline MK, Hastings SB, Amoah KA, Zhang S, Conroy JM, Jensen TJ, Eisenberg M, Caveney B, Severson EA, Ramkissoon S, Gandhi S
Breast Cancer: Targets and Therapy 2024, 16:483-495
Published Date: 23 August 2024
Insights into the Refusal of Free Screening Mammograms: Exploring Contributing Factors
Alshamsan B, Alajlan T, Alsalhi A, Rabbani U
Breast Cancer: Targets and Therapy 2024, 16:471-481
Published Date: 17 August 2024
Shenqi Fuzheng Injection Reduces Cisplatin-Induced Kidney Injury via cGAS/STING Signaling Pathway in Breast Cancer Mice Model
Ma Y, Bai B, Liu D, Shi R, Zhou Q
Breast Cancer: Targets and Therapy 2024, 16:451-469
Published Date: 16 August 2024
Dosimetric Study and Robustness Analysis of Base Note Intensive Locked Field Radiotherapy for Left Breast Cancer
Tang C, Cao Q, Ai X
Breast Cancer: Targets and Therapy 2024, 16:433-450
Published Date: 30 July 2024
Hypofractionated versus Conventional Postmastectomy Irradiation for Breast Cancer: Comparison of Acute Skin Toxicity
Wu Z, Hou L, Li C, Li X, Li Y
Breast Cancer: Targets and Therapy 2024, 16:423-432
Published Date: 30 July 2024
Consistency of CSCO AI with Multidisciplinary Clinical Decision-Making Teams in Breast Cancer: A Retrospective Study
Xu W, Wang X, Yang L, Meng M, Sun C, Li W, Li J, Zheng L, Tang T, Jia W, Chen X
Breast Cancer: Targets and Therapy 2024, 16:413-422
Published Date: 29 July 2024
The Prognostic Value of Serum Albumin to Globulin Ratio in Patients with Breast Cancer: A Retrospective Study
Pan C, Gu Y, Ni Q
Breast Cancer: Targets and Therapy 2024, 16:403-411
Published Date: 25 July 2024
Predictive Value of Pretreatment Neutrophil to Albumin Ratio in Response to Neoadjuvant Chemotherapy of Breast Cancer
Deng YX, Zhao YJ, Nong QH, Qiu HM, Guo QL, Hu H
Breast Cancer: Targets and Therapy 2024, 16:393-402
Published Date: 23 July 2024
Brain Radiotherapy Combined with Targeted Therapy for HER2-Positive Breast Cancer Patients with Brain Metastases
Tang L, Zhang W, Chen L
Breast Cancer: Targets and Therapy 2024, 16:379-392
Published Date: 22 July 2024
Metabolomics in Radiotherapy-Induced Early Adverse Skin Reactions of Breast Cancer Patients
McMahon AN, Lee E, Takita C, Reis IM, Wright JL, Hu JJ
Breast Cancer: Targets and Therapy 2024, 16:369-377
Published Date: 16 July 2024
Breast Cancer Adjuvant Radiotherapy in Up-Front to Chemotherapy: Is There a Worthwhile Benefit? A Preliminary Report
Lazzari G, Benevento I, Montagna A, D'Andrea B, De Marco G, Castaldo G, Bianculli A, Tucciariello R, Metallo V, Solazzo AP
Breast Cancer: Targets and Therapy 2024, 16:359-367
Published Date: 15 July 2024
Research Progress on Ferroptosis and Nanotechnology-Based Treatment in Triple-Negative Breast Cancer
Zhang J, Zhang S, Liu M, Yang Z, Huang R
Breast Cancer: Targets and Therapy 2024, 16:347-358
Published Date: 15 July 2024
Role of AURKB Inhibition in Reducing Proliferation and Enhancing Effects of Radiotherapy in Triple-Negative Breast Cancer
Pellizzari S, Athwal H, Bonvissuto AC, Parsyan A
Breast Cancer: Targets and Therapy 2024, 16:341-346
Published Date: 9 July 2024
The Effect of C-Reactive Protein/Lymphocyte Ratio (CLR) on PFS in Metastatic Breast Cancer Patients Treated with CDK4/6 Inhibitors: A Novel Biomarker
Buyukbayram ME, Hannarici Z, Duzkopru Y, Turhan A, Caglar AA, Coban Esdur P, Bilici M, Tekin SB, Yazılıtaş D
Breast Cancer: Targets and Therapy 2024, 16:329-339
Published Date: 3 July 2024
Unveiling Paclitaxel-Induced Mesenchymal Stem Cells: orchestrating Nrf2 Modulation and Apoptosis in CD44+/CD24- Cancer Stem Cells
Hermansyah D, Syarifah S, Muhar AM, Putra A
Breast Cancer: Targets and Therapy 2024, 16:319-328
Published Date: 2 July 2024
Analysis of the Value of Quantitative Features in Multimodal MRI Images to Construct a Radio-Omics Model for Breast Cancer Diagnosis
Zhang Z, Lan H, Zhao S
Breast Cancer: Targets and Therapy 2024, 16:305-318
Published Date: 11 June 2024
Modulatory Effects of XIAOPI Formula on CXCL1 and Selected Outcomes in Triple-Negative Breast Cancer: A Randomized Controlled Clinical Trial
Guo L, Hong SC, Wang X, Wang SQ, Wang N, Wei XQ, Situ HL, Wang ZY
Breast Cancer: Targets and Therapy 2024, 16:289-303
Published Date: 31 May 2024
Comparative Analysis of Women’s Breast Cancer Survival Time at Three Selected Government Referral Hospitals in Ethiopia’s Amhara Region Using Parametric Shared Frailty Models
Fentaw S, Godana AA, Abathun D, Chekole DM
Breast Cancer: Targets and Therapy 2024, 16:269-287
Published Date: 29 May 2024
Retrospective Analysis of Pyrotinib-Based Therapy for Metastatic Breast Cancer: Promising Efficacy in Combination with Trastuzumab
Gu Q, Zhu M, Wang Y, Gu Y
Breast Cancer: Targets and Therapy 2024, 16:253-268
Published Date: 25 May 2024
Correlation Analysis of Digital Mammography, Ultrasonography, and Pathologic Features in Pure Invasive Micropapillary Carcinoma of the Breast (PIMPC)
Sui X, Feng P, Sun X, Liang P, Liu Y, Zhang G
Breast Cancer: Targets and Therapy 2024, 16:245-252
Published Date: 25 April 2024
Expression and Significance of LINC02418 in Breast Cancer
Zhou YH, Huang JY
Breast Cancer: Targets and Therapy 2024, 16:233-243
Published Date: 24 April 2024
Does the Dose of Standard Adjuvant Chemotherapy Affect the Triple-negative Breast Cancer Benefit from Extended Capecitabine Metronomic Therapy? An Exploratory Analysis of the SYSUCC-001 Trial
Chen Y, Li WX, Wu JH, Chen GH, Yang CM, Lu H, Wang X, Wang SS, Huang H, Cai L, Zhao L, Peng RJ, Lin Y, Tang J, Zeng J, Zhang LH, Ke YL, Wang XM, Liu XM, Zhang AQ, Xu F, Bi XW, Huang JJ, Li JB, Pang DM, Xue C, Shi YX, He ZY, Lin HX, An X, Xia W, Cao Y, Guo Y, Hong RX, Jiang KK, Zhong YY, Zhang G, Tienchaiananda P, Oikawa M, Yuan ZY, Chen QJ
Breast Cancer: Targets and Therapy 2024, 16:223-231
Published Date: 12 April 2024
Serum HER2 Level Predicts Therapeutic Efficacy and Prognosis in Advanced Breast Cancer Patients [Letter]
Syahruddin FI, Prihantono, Muis M
Breast Cancer: Targets and Therapy 2024, 16:221-222
Published Date: 11 April 2024
Identification and Validation of Novel Metastasis-Related Immune Gene Signature in Breast Cancer
Ma S, Hao R, Lu YW, Wang HP, Hu J, Qi YX
Breast Cancer: Targets and Therapy 2024, 16:199-219
Published Date: 12 April 2024
Therapy for Hormone Receptor-Positive, Human Epidermal Growth Receptor 2-Negative Metastatic Breast Cancer Following Treatment Progression via CDK4/6 Inhibitors: A Literature Review
Ye M, Xu H, Ding J, Jiang L
Breast Cancer: Targets and Therapy 2024, 16:181-197
Published Date: 10 April 2024
Serum HER2 Level Predicts Therapeutic Efficacy and Prognosis in Advanced Breast Cancer Patients
Wang S, Chen Y, Li W, Hao C, Zhang L, Zhao W, Shi Y, Tong Z
Breast Cancer: Targets and Therapy 2024, 16:163-179
Published Date: 3 April 2024
Amplifying Immune Responses: Microparticulate Vaccine Approach Against Breast Cancer
Ubowski MM, VanSice R, Marriott M, Yacobucci MJ, Chablani L
Breast Cancer: Targets and Therapy 2024, 16:149-162
Published Date: 28 March 2024
HER2 Low Expression in Primary Male Breast Cancer
Nobbe K, Erices-Leclercq M, Foerster F, Förster R, Baldus SE, Rudlowski C, Schröder L, Lubig S
Breast Cancer: Targets and Therapy 2024, 16:141-148
Published Date: 28 March 2024
ZNF217 Gene Copy Number as a Marker of Response to Standard Therapy Drugs According to ERα Status in Breast Cancer
Rangel N, Sánchez IL, Valbuena DS, Rondón-Lagos M
Breast Cancer: Targets and Therapy 2024, 16:127-139
Published Date: 15 March 2024
The Role of Ki-67 in HR+/HER2- Breast Cancer: A Real-World Study of 956 Patients
Ma Q, Liu YB, She T, Liu XL
Breast Cancer: Targets and Therapy 2024, 16:117-126
Published Date: 8 March 2024
Clinical Outcomes of Patients with HER2 Positive Metastatic Breast Cancer to the Brain, with First-Line Trastuzumab, Pertuzumab and Chemotherapy, in a Real-World Setting
Sharman Moser S, Apter L, Livnat I, Ginsburg R, Yarden A, Drori M, Drizon A, Chodick G, Siegelmann-Danieli N
Breast Cancer: Targets and Therapy 2024, 16:105-116
Published Date: 6 March 2024
An Analysis of Preoperative Inflammatory Indicators That Influence the Drainage Tube Retention Time in Patients with Breast Cancer Surgery
Li Q, Gao C, Zhao X, Li J, Shen Q, Chen L
Breast Cancer: Targets and Therapy 2024, 16:91-103
Published Date: 6 March 2024
GNPNAT1 is a Biomarker That Predicts a Poor Prognosis of Breast Cancer
Zhou Y, Xue W, Meng X, Bhandari A, Zeng H, KC R, Hirachan S, Xia E
Breast Cancer: Targets and Therapy 2024, 16:71-89
Published Date: 5 March 2024
Antibody-Drug Conjugates in Breast Cancer: A Comprehensive Review of How to Selectively Deliver Payloads
Monteiro MR, Nunes NCC, Junior AADS, Fêde ABDS, Bretas GDO, Souza CDP, Mano M, da Silva JL
Breast Cancer: Targets and Therapy 2024, 16:51-70
Published Date: 28 February 2024
Does Nipple-Ward Positive Margin Contribute to a Higher Rate of Re-Excision Procedures After a Lumpectomy with Pathology-Confirmed Positive Margins? A Retrospective Study
Bhimani F, Lin S, McEvoy M, Cavalli A, Obaid L, Chen Y, Gupta A, Pastoriza J, Shihabi A, Feldman S
Breast Cancer: Targets and Therapy 2024, 16:41-50
Published Date: 21 February 2024
Pretreatment Circulating Albumin, Platelet, and RDW-SD Associated with Worse Disease-Free Survival in Patients with Breast Cancer
Chen CC, Tang WH, Wu CC, Lee TL, Tsai IT, Hsuan CF, Wang CP, Chung FM, Lee YJ, Yu TH, Wei CT
Breast Cancer: Targets and Therapy 2024, 16:23-39
Published Date: 16 January 2024
Thyroid Hormone Changes Correlate to Combined Breast Cancer with Primary Thyroid Cancer
Jin J, Li J, Liu Y, Shi Q, Zhang B, Ji Y, Hu P
Breast Cancer: Targets and Therapy 2024, 16:15-22
Published Date: 9 January 2024
The Programmed Cell Death Ligand 1 and Lipocalin 2 Expressions in Primary Breast Cancer and Their Associations with Molecular Subtypes and Prognostic Factors
Ekemen S, Bilir E, Soultan HEA, Zafar S, Demir F, Tabandeh B, Toprak S, Yapicier O, Coban C
Breast Cancer: Targets and Therapy 2024, 16:1-13
Published Date: 3 January 2024